SE: AI is disruptive to EDA, the semiconductor industry, and to their customers. One early indication is that computer ...

In laboratory and rainy-season field trials in Veracruz, Mexico, black soldier fly larvae reduced organic waste faster, ...

Qure's AMT-130 data likely remains strong enough to support accelerated approval, which isn't priced into the stock at the ...

It’s nice to have more tools in the toolbox so that we’re not trying to fit a square peg in a round hole,” one expert says.

<?xml encoding="utf-8" ?> Revolution Medicines RVMD reported third-quarter financial results on Wednesday. The transcript ...

Biologics License Application for sonelokimab submitted to the U.S. Food and Drug Administration for the treatment of adults and adolescents with ...

Palisade Bio's phase 2b ASCENTRA-UC trial for ulcerative colitis has begun dosing, with 12-week topline results expected in Q4 2027. I rate PALI stock as Buy.

Forever▲12GTA 6▼13Call of Duty: Modern Warfare IV–4The Legend of Zelda: Ocarina of Time (Remake)–5Final Fantasy ...

Pelareorep-driven changes in the tumor microenvironment are associated with tumor responses and shrinkageImmune activation levels more than ...

The best sweepstakes casinos in 2026, featuring welcome bonuses, game libraries, mobile access and availability across the ...

Abstracts include clinical, translational and biomarker findings in higher-risk MDS, a new post-hypomethylating agent survival benchmark, and the randomized Phase 2b BEXERA trial in progressTURKU, FI ...

Patients with interstitial lung disease and an underlying autoimmune condition demonstrate a lower mortality risk than those with idiopathic disease.